{"id":"W2620384985","doi":"10.1182/blood.v128.22.4507.4507","title":"Oncolytic Reovirus Immune Priming: A Phase 1b Study of Reolysin with Bortezomib and Dexamethasone in Patients with Relapsed/Refractory Multiple Myeloma","year":2016,"lang":"en","type":"article","venue":"Blood","topic":"Virus-based gene therapy research","field":"Biochemistry, Genetics and Molecular Biology","cited_by":9,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Medicine; Pomalidomide; Internal medicine; Refractory (planetary science); Multiple myeloma; Bortezomib; Cohort; Carfilzomib; Gastroenterology; Dexamethasone; Toxicity; Surgery; Biology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001385891,0.001455363,0.00157207,0.0003927104,0.0004998565,0.0008032377,0.0008531087,0.0009604471,0.001911171],"category_scores_gemma":[0.0005747749,0.0005234114,0.001023447,0.00038831,0.0008706171,0.0007502525,0.0004370302,0.003326952,0.0004633163],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008911467,"about_ca_system_score_gemma":0.001329728,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001045029,"about_ca_topic_score_gemma":0.001704852,"domain_scores_codex":[0.9995902,0.0001795847,0.00002177899,0.00007650481,0.00003733322,0.00009457667],"domain_scores_gemma":[0.9994172,0.00007767998,0.000116617,0.00004749696,0.00003181323,0.0003092268],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.4266657,0.2494437,0.01481066,0.0008732516,0.001250254,0.0006824384,0.001025003,0.003911997,0.1653326,0.0003258094,0.002692705,0.1329859],"study_design_scores_gemma":[0.1847452,0.7882211,0.0150572,0.00003456792,0.0002519775,0.0003457193,0.00008936263,0.0008357805,0.008691858,0.0001013289,0.001600831,0.00002515291],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9972172,0.0008786685,0.0002169074,0.0001715265,0.00003670537,0.0008375475,0.0001970613,0.00003272099,0.0004116521],"genre_scores_gemma":[0.9958333,0.0006851839,0.0009362809,0.0003148612,0.00009875031,0.0008838361,0.000532283,0.00001310706,0.0007023034],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001911171,"threshold_uncertainty_score":0.007329404,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01235444526356971,"score_gpt":0.2679979485087741,"score_spread":0.2556435032452044,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}